Refractive and topographic results of benzalkonium chloride–assisted transepithelial crosslinking
- 1 June 2012
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Cataract & Refractive Surgery
- Vol. 38 (6), 1000-1005
- https://doi.org/10.1016/j.jcrs.2012.01.024
Abstract
To evaluate the effect of benzalkonium chloride-assisted (BAC) transepithelial collagen crosslinking (CXL) in eyes with progressive keratoconus and a minimum follow-up of 6 months. Department of Ophthalmology, Antwerp University Hospital, Antwerp, Belgium. Cohort study. Eyes with progressive keratoconus had CXL treatment without epithelial debridement. The standard CXL irradiation was preceded by instillation of proparacaine drops 0.5% preserved with BAC 0.005% every 5 minutes for 30 minutes. Selected parameters of refraction assessed by Placido disk (Eyesys) and Scheimpflug (Pentacam) examinations were compared before CXL and after CXL at 6, 12, and 18 months. The study enrolled 53 eyes of 38 patients. Sphere, cylinder, as well as maximum keratometry (K max) simulated K values (steep, flat, astigmatism), and refractive power values (steep, flat, astigmatism) measured using the Placido disk device remained stable over the 18-month follow-up. Only corrected distance visual acuity showed a statistically significant improvement at 6 months and 12 months. The Scheimpflug device measurements of maximum K and pachymetry at the thinnest point showed statistically significant progression throughout the study. No patient developed corneal haze or other complications. Transepithelial CXL using proparacaine drops 0.5% preserved with BAC 0.005% was less effective than standard CXL in stabilizing progressive keratoconus.Keywords
This publication has 28 references indexed in Scilit:
- Riboflavin/Ultraviolet A Corneal Collagen Cross-linking for the Treatment of Keratoconus: Visual Outcomes and Scheimpflug AnalysisCornea, 2011
- Long-term Results of Riboflavin Ultraviolet A Corneal Collagen Cross-linking for Keratoconus in Italy: The Siena Eye Cross StudyAmerican Journal of Ophthalmology, 2010
- Scheimpflug Imaging of Corneas After Collagen Cross-LinkingCornea, 2009
- Contralateral Eye Study of Corneal Collagen Cross-linking With Riboflavin and UVA Irradiation in Patients With KeratoconusJournal of Refractive Surgery, 2009
- Refractive, Topographic, Tomographic, and Aberrometric Analysis of Keratoconic Eyes Undergoing Corneal Cross-LinkingOphthalmology, 2009
- Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: Long-term resultsJournal of Cataract & Refractive Surgery, 2008
- Effect of complete epithelial debridement before riboflavin–ultraviolet-A corneal collagen crosslinking therapyJournal of Cataract & Refractive Surgery, 2008
- A Randomized Controlled Trial of Corneal Collagen Cross-linking in Progressive Keratoconus: Preliminary ResultsJournal of Refractive Surgery, 2008
- Parasurgical therapy for keratoconus by riboflavin–ultraviolet type A rays induced cross-linking of corneal collagenJournal of Cataract & Refractive Surgery, 2006
- Riboflavin/ultraviolet-a–induced collagen crosslinking for the treatment of keratoconusAmerican Journal of Ophthalmology, 2003